.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
McKinsey
Accenture
Dow
Merck
Daiichi Sankyo
Fish and Richardson
Moodys
Baxter
US Department of Justice

Generated: June 23, 2017

DrugPatentWatch Database Preview

BUPIVACAINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Bupivacaine Hydrochloride, and when can generic versions of Bupivacaine Hydrochloride launch?

Bupivacaine Hydrochloride is a drug marketed by Sagent Agila, Hospira, Claris, Aurobindo Pharma Ltd, Septodont, and Intl Medicated. and is included in twenty-six NDAs.

The generic ingredient in BUPIVACAINE HYDROCHLORIDE is bupivacaine hydrochloride; epinephrine. There are ten drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine profile page.

Summary for Tradename: BUPIVACAINE HYDROCHLORIDE

Patents:0
Applicants:6
NDAs:26
Suppliers / Packagers: see list6
Bulk Api Vendors: see list62
Clinical Trials: see list2,854
Patent Applications: see list488
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BUPIVACAINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: BUPIVACAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sagent Agila
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
bupivacaine hydrochloride
INJECTABLE;INJECTION091487-002Oct 18, 2011APRXNoNo► Subscribe► Subscribe
Hospira
BUPIVACAINE HYDROCHLORIDE KIT
bupivacaine hydrochloride
INJECTABLE;INJECTION019978-003Sep 3, 1992DISCNNoNo► Subscribe► Subscribe
Sagent Agila
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
bupivacaine hydrochloride
INJECTABLE;INJECTION091487-001Oct 18, 2011APRXNoNo► Subscribe► Subscribe
Intl Medicated
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
bupivacaine hydrochloride
INJECTABLE;INJECTION076012-001Jan 9, 2002DISCNNoNo► Subscribe► Subscribe
Sagent Agila
BUPIVACAINE HYDROCHLORIDE
bupivacaine hydrochloride
INJECTABLE;INJECTION091503-001Oct 18, 2011APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Healthtrust
Dow
Chinese Patent Office
Cerilliant
US Department of Justice
Baxter
Boehringer Ingelheim
Moodys
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot